The Black Technology Era of Xueba

: Chapter 522 Detonating the Medical World (3)

If Xiao Ming cares about the reports from the Western media and wants every experiment of Pangu Science and Technology to make Western media happy and applaud himself, then Pangu Technology does not need to conduct experiments for R & D.

When will the West be happy for Pangu Technology, and one day Pangu Technology will declare bankruptcy, then Western media will be very happy.

Gao Siqi has compiled the method of NK gene induction treatment of Ebola, including specific theory and detailed laboratory research process and ten successful cases of treatment in the epidemic area of ​​northern South Africa.

This paper will be published in Xia Guo's relevant academic journals, and the treatment method will be notified to Xia Guo's disease control center and related first-line disease control hospitals.

The NK gene induction therapy method will become a landmark method for Xia Guo to treat viral infections. This method can not only be used to treat Ebola and seasonal influenza. After in-depth research and improvement, it can also be used with vaccines for treatment. Viral infections can even be used to treat HIV.

Pangu Technology cares about the health of the people of Xia Kingdom, and is an anti-virus medical industry in Xia Kingdom. As for whether the Western world cares or criticizes, this is not what Xiao Ming cares about.

After Xia Guo's disease control and medical department obtained the experimental papers and actual cases of Pangu Technology, he repeatedly confirmed the authenticity of the content to Pangu Technology, and finally contacted Xia Guo's medical team in South Africa to confirm that he was responsible for Most of the patients in the Ebola epidemic area did receive effective treatment, not only the epidemic situation was controlled, but many of the patients were also in danger.

Yan Jing, the Institute of Virology of Xia National Academy of Sciences, Xia Guo's major medical universities and virology experts gathered together. The purpose of this symposium was to study the NK gene induction therapy proposed by Pangu Technology.

Zheng Xuanyu also rushed from Jiangcheng to Yanjing to explain the specific content of treatment methods for these professors and experts.

Zheng Xuanyu participated in the whole process of experiment and treatment, and her explanation was better than these experts and professors' wild guesses.

The symposium began at 9 am and ended at 6 pm. After Zheng Xuanyu explained the last part, all the experts and professors at the scene stood up and gave warm applause to Zheng Xuanyu.

Zheng Xuanyu also quickly stood up and bowed to everyone, saying very embarrassedly: "Because NK therapy still needs to undergo a large number of clinical tests, there is something wrong with it, please correct me a lot."

Zheng Xuanyu's teacher, Professor Chen of Yanjing University School of Medicine, was also present. He was very satisfied with his student and kept nodding. "Xuan Yu, at the beginning, you said that you didn't want to go to graduate school of this university. My experimental tutor and I Some regrets, it seems that Pangu Technology can bring you more than the school gives you. Congratulations, congratulations to your laboratory! "

Zheng Xuanyu said very modestly: "Professor Chen has passed the award."

Professor Xia Guo, a virologist, said, "We cannot blame Pangu Technology for skipping the steps of experimental review and animal experiments. Special problems are dealt with specifically. Ebola is terrible. The vaccines in Maple Leaf Country are unreliable. Don't let those patients wait. "

Professor Chen nodded in agreement, saying, "In the name of Xia Guo CDC and Xia Guo Key Laboratory of Molecular Virology and Immunology, we formally recommend that WHO use NK gene induction therapy as the main treatment for Ebola."

Professor Chen also told Zheng Xuanyu: "We hope to establish a cooperative relationship with Pangu Technology, further study NK therapy, and prepare for influenza, HIV, etc. Xuan Yu, I hope you can go back and talk to the company."

"Professor Chen, rest assured!" Zheng Xuanyu said, "Xiao Ming had already planned to cooperate with the best molecular virus laboratory in the country. The head of our laboratory, Gao Siqi Xue, was also your auditing student. It was yours. What about fans. "

"Hahahaha! That's all right, this is all right!" Professor Chen was full of heart.

On the second day, the Xia National Academy of Sciences Key Laboratory of Molecular Virology and Immunity and the Xia Guo Center for Disease Control and Prevention jointly published the article "Feasibility Demonstration of NK Cell Group Gene Induction Therapy for Ebola Virus" in Pangu Technology Life Science Laboratory.

The article published the relevant information of the materials submitted by Pangu Technology without fail, and identified and commented on it.

In the stated statement, the article said: This treatment method has opened a new way for human and viral wars, and NK cell population gene induction therapy will provide new ways for influenza, HIV, hepatitis B ... therapeutic methods.

This is definitely a major event in the global medical community.

At 7 o'clock in the evening of Xia Guo that night, the anchor introduced the method of NK cell gene induction therapy for one minute and 30 seconds, and used the pictures taken by Xia Guo's medical team in the epidemic area of ​​northern South Africa.

The female anchor reported with a passionate and full voice: "The successful experiment of NK cell gene induction therapy has declared that human infection with Ebola virus can be completely cured ... At present, the Xia Guo medical team has adopted this method in South Africa. For local Ebola patients, 30 people have recovered and 120 continue to receive treatment ... "

With the affirmation of the state, the entire cost of treatment in the Nan'an Pest Free Area does not need to worry about Pangu technology.

The news spread to Europe and North America, and major medical research institutes were stunned.

Ebola ... conquered by Pangu Technology?

This is not a vaccine but a treatment after the illness.

How is this inconsistent with the BBC and Global Post reports?

"Impossible!" NL Gene Pharmaceuticals' P4 laboratory, this is the birthplace of the Ebola vaccine.

Chief vaccine and virologist Kevins saw Xia Guo ’s report and said, “NK cell populations? NK cell populations require a healthy bone marrow and immune system to produce. It is absolutely impossible for the human immune system to be trapped by a virus. NK cell population! "

But when Kevins saw the experimental paper of Pangu Technology in detail, his goose bumps were all up. This treatment is absolutely impossible for NL, but for Pangu Technology, which has mastered gene regulation and expression technology, Really possible.

Kevins slumped in his seat at once ~ www.NovelMTL.com ~ murmured: "Western biomedicine will be completely surpassed by Xia Guo ..."

The WHO also received two messages at the same time.

One is that although the NK treatment method does not comply with WHO's biomedical experimental methods, it has achieved success, and the Ebola epidemic in South Africa's pest free area has been controlled.

One is in the Congo, where the epidemic area opposite the United Medical Team composed of multinational medical institutions including Rice, Maple Leaf, and J countries lost control, and 300 people died last week, and two Maple Leaf doctors infected Ebo. Pull.

The situation of the two doctors was very critical, and they requested WHO to send an expert team to the epidemic area for emergency treatment.

The most terrifying thing is that the two Maple Leaf Doctors were injected with NL's vaccine in advance, which means that the Ebola on site was a variant of the vaccine disease strain.

The medical team has applied to the WHO for evacuation, and medical personnel matter, but for those in the affected area, the joint medical team can only wait for them to survive.

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like